• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat.Com. Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy

tetano

Editor, Senior Moderator
Nat Commun. 2017 Jul 12;8(1):69. doi: 10.1038/s41467-017-00057-x.
[h=1]Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy.[/h] To EE[SUP]1,[/SUP][SUP]2[/SUP], Vlahos R[SUP]1[/SUP], Luong R[SUP]2[/SUP], Halls ML[SUP]3[/SUP], Reading PC[SUP]4[/SUP], King PT[SUP]5[/SUP], Chan C[SUP]2,[/SUP][SUP]6[/SUP], Drummond GR[SUP]7[/SUP], Sobey CG[SUP]7[/SUP], Broughton BRS[SUP]2[/SUP], Starkey MR[SUP]8[/SUP], van der Sluis R[SUP]9[/SUP], Lewin SR[SUP]9,[/SUP][SUP]10[/SUP], Bozinovski S[SUP]1[/SUP], O'Neill LAJ[SUP]11[/SUP], Quach T[SUP]12,[/SUP][SUP]13,[/SUP][SUP]14[/SUP], Porter CJH[SUP]12,[/SUP][SUP]14[/SUP], Brooks DA[SUP]15[/SUP], O'Leary JJ[SUP]16,[/SUP][SUP]17,[/SUP][SUP]18[/SUP], Selemidis S[SUP]19,[/SUP][SUP]20[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The imminent threat of viral epidemics and pandemics dictates a need for therapeutic approaches that target viral pathology irrespective of the infecting strain. Reactive oxygen species are ancient processes that protect plants, fungi and animals against invading pathogens including bacteria. However, in mammals reactive oxygen species production paradoxically promotes virus pathogenicity by mechanisms not yet defined. Here we identify that the primary enzymatic source of reactive oxygen species, NOX2 oxidase, is activated by single stranded RNA and DNA viruses in endocytic compartments resulting in endosomal hydrogen peroxide generation, which suppresses antiviral and humoral signaling networks via modification of a unique, highly conserved cysteine residue (Cys98) on Toll-like receptor-7. Accordingly, targeted inhibition of endosomal reactive oxygen species production abrogates influenza A virus pathogenicity. We conclude that endosomal reactive oxygen species promote fundamental molecular mechanisms of viral pathogenicity, and the specific targeting of this pathogenic process with endosomal-targeted reactive oxygen species inhibitors has implications for the treatment of viral disease.Production of reactive oxygen species is an ancient antimicrobial mechanism, but its role in antiviral defense in mammals is unclear. Here, To et al. show that virus infection activates endosomal NOX2 oxidase and restricts TLR7 signaling, and that an endosomal NOX2 inhibitor decreases viral pathogenicity.


PMID: 28701733 DOI: 10.1038/s41467-017-00057-x
 
Back
Top Bottom